Trial
NCT01602016
A Folinic Acid Intervention for Autism Spectrum Disorders
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Arkansas
Collaborators
Arkansas Children's Hospital Research Institute
Condition
Autism Spectrum Disorder
Intervention
Folinic Acid and placebo
Why stopped
Non-compliance
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-17